Preliminary phase III efficacy and safety of alemtuzumab vs chlorambucil as front-line therapy leukemia (BCLL)

• HILLMEN P

収録刊行物

• Proc ASCO

  Proc ASCO 24 6511-, 2006

詳細情報

• CRID: 1571417125569891584
• NII論文ID: 10021930607
• データソース種別:
  • CiNii Articles